Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Enhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment.

× No keyword cloud information.

12 in total

1. Effects of sustained administration of quetiapine alone and in combination with a serotonin reuptake inhibitor on norepinephrine and serotonin transmission.

Authors: Olga Chernoloz; Mostafa El Mansari; Pierre Blier
Journal: Neuropsychopharmacology Date: 2012-02-29 Impact factor: 7.853

2. A single dose of antidepressant alters eye-gaze patterns across face stimuli in healthy women.

Authors: R Jonassen; O Chelnokova; C Harmer; S Leknes; N I Landrø
Journal: Psychopharmacology (Berl) Date: 2014-09-07 Impact factor: 4.530

3. Vilazodone: a brief pharmacological and clinical review of the novel serotonin partial agonist and reuptake inhibitor.

Authors: Thomas L Schwartz; Umar A Siddiqui; Stephen M Stahl
Journal: Ther Adv Psychopharmacol Date: 2011-06

4. Antidepressant Use and Subclinical Measures of Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis.

Authors: Álvaro Camacho; Robyn L McClelland; Joseph A Delaney; Matthew A Allison; Bruce M Psaty; Dena E Rifkin; Stephen R Rapp; Moyses Szklo; Murray B Stein; Michael H Criqui
Journal: J Clin Psychopharmacol Date: 2016-08 Impact factor: 3.153

5. Significance of dietary folate intake, homocysteine levels and MTHFR 677 C>T genotyping in South African patients diagnosed with depression: test development for clinical application.

Authors: Darnielle Delport; Renata Schoeman; Nicole van der Merwe; Lize van der Merwe; Leslie R Fisher; Dieter Geiger; Maritha J Kotze
Journal: Metab Brain Dis Date: 2014-02-18 Impact factor: 3.584

6. Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use.

Authors: Mandeep Singh; Thomas L Schwartz
Journal: Neuropsychiatr Dis Treat Date: 2012-03-23 Impact factor: 2.570

Review 7. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction.

Authors: Alan L Pehrson; Connie Sanchez
Journal: CNS Spectr Date: 2013-08-01 Impact factor: 3.790

Enhancing outcomes from major depression: using antidepressant combination therapies with multifunctional pharmacologic mechanisms from the initiation of treatment.